Expression of pro-apoptotic (p53, p21, bax, bak and fas) and anti-apoptotic (bcl-2 and bcl-x) proteins in serous versus mucinous borderline ovarian tumours
Authors:
- 15 December 2005
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 92 (4) , 337-343
Abstract
Background We examined the expression of apoptosis‐related proteins in serous versus mucinous borderline ovarian tumours, in comparison with benign and malignant ovarian tumours. Materials and Methods Immunohistochemical expression of pro‐apoptotic (p53, p21, bax, bak, fas) and anti‐apoptotic proteins (bcl‐2, bcl‐x) was determined in 34 borderline (19 mucinous, 15 serous), 20 benign (10 mucinous, 10 serous) and 28 malignant ovarian tumours (9 mucinous, 19 serous). Results A difference in semi‐quantitative p53 expression was found between benign and borderline tumours (P = 0.01), but not between borderline and malignant tumours. Increased p21 expression was found in borderline versus benign tumours (P = 0.004). Bcl‐2 expression was lower in borderline than in benign (P = 0.01) and malignant tumours (P = 0.02). No difference in bax, bak, fas or bcl‐x expression was observed among the three tumour types. Higher percentage of p21 positive cells was found in serous than in mucinous borderline tumours (P < 0.001). Bcl‐2 expression was higher in serous than in mucinous forms of benign (P < 0.001), borderline (P < 0.001), and malignant tumours (P < 0.003). No difference in p53, bax, bak, fas or bcl‐x expression was observed between serous and mucinous borderline ovarian tumours. Conclusion Although p53 overexpression was a common feature of both mucinous and serous borderline tumours, p21 and bcl‐2 overexpression appeared specific to serous tumours. J. Surg. Oncol. 2005;92:337–343.Keywords
This publication has 26 references indexed in Scilit:
- Precursor lesions of ovarian epithelial malignancyHistopathology, 2001
- Ovarian serous borderline tumors: A critical review of the literature with emphasis on prognostic indicatorsHuman Pathology, 2000
- Tissue-Specific Bcl-2 Protein Partners in Apoptosis: An Ovarian ParadigmPhysiological Reviews, 2000
- Prognostic Significance of p53 and p21waf1/cip1 Immunoreactivity in Epithelial Cancers of the OvaryGynecologic Oncology, 1999
- The Cell of Origin of Ovarian Epithelial Tumors and the Ovarian Surface Epithelium Dogma: Does the Emperor Have No Clothes?Gynecologic Oncology, 1999
- Histological Features of the Contralateral Ovary in Patients with Unilateral Ovarian Cancer: A Case Control StudyGynecologic Oncology, 1998
- p53 gene analysis of ovarian borderline tumors and stage I carcinomas*1Human Pathology, 1995
- Contralateral Ovary in Unilateral Ovarian CarcinomaInternational Journal of Gynecological Pathology, 1993
- Ovarian intraepithelial neoplasia demonstrated in patients with stage I ovarian carcinomaGynecologic Oncology, 1990
- Ovarian epithelial tumors of borderline malignancy: A clinical and pathologic study of 109 casesCancer, 1986